Praveen Yalamanchili, MD
Orthopaedic Surgery · Atlanta, GANPI 1982841920
Payments from drug & device makers
Across 64 payments — averaging $271.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$16K
- Nevro Corp.$455
- Zimvie Inc.$440
- Alphatec Spine, Inc$187
- Augmedics Inc.$149
- Carlsmed, Inc.$140
- plus $420 from 13 others
What the payments were for
- Consulting fees$9,85057%
- Speaking & faculty fees$2,40014%
- Travel & lodging$2,88717%
- Food & beverage$1,78710%
- Education$4403%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical(2 entities) | 25 | $15,573 |
| Nevro Corp. | 11 | $455 |
| Zimvie Inc. | 4 | $440 |
| Alphatec Spine, Inc | 2 | $187 |
| Augmedics Inc. | 1 | $149 |
| Carlsmed, Inc. | 1 | $140 |
| Johnson & Johnson | 4 | $73 |
| Cerapedics Inc. | 3 | $68 |
| 4web, Inc. | 1 | $44 |
| Smith+Nephew | 1 | $40 |
| Si-bone, Inc. | 3 | $38 |
| Acumed LLC | 1 | $37 |
| Stryker | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Spine Wave, Inc. | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Vertex | 1 | $15 |
| Boston Scientific | 1 | $14 |
| Heron Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xpand / Xpand-R$4,000
- Expanding FOOTPRINT$3,800
- ELSA$3,750
- CREO$795
- CREO 5.5$795
- Excelsius - GPS$792
- Xvision$745
- 3D Printed Cervical Interbody$500
- Biomet SpinalPak Non-invasive Spine Fusion Stimulator System$377
- Excelsius Robotics System$375
- Bi-Directional Exp Footprint$200
- INVICTUS OPEN$162
- aprevo$140
How this compares
$17,364 in reported general payments places this provider in the 75th percentile of 654 orthopaedic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 107 | $640 |
| Naproxen | 34 | $296 |
| Cyclobenzaprine Hcl | 29 | $203 |
| Gabapentin | 12 | $118 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $84 |
| Tramadol Hcl | 20 | $80 |
| Meloxicam | 17 | $36 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Atlanta
- Daniel SilcoxAtlanta$3.4M
- Dennis DevitoAtlanta$1.5M
- Erroll BaileyAtlanta$536K
- Hardeep SinghAtlanta$451K
- Jorge FabregasAtlanta$421K
- Ezequiel CassinelliAtlanta$225K
- Timothy OswaldAtlanta$220K
- James ChappuisAtlanta$206K
- Michael SchmitzAtlanta$162K
- Samuel WillimonAtlanta$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.